Of note, a higher serum level of CCR5 ligands such as CCL3 and CCL5 has been found in MS patients, although the effects of these ligands on the disease has yet to be elucidated (Khaiboullina et al. 2015). The gene discussed is CCR5; the disease is myeloid sarcoma.